+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
SURAKSHA

Suraksha Diagnostic Share Price

₹335.65 -4.45 (-1.31%)
New 52W High today

09 Sep, 2026 3:54 PM (IST)

Suraksha Diagnostic live price: ₹335.65. It opened at ₹335 vs previous close ₹340; intraday high/low: ₹349/₹334. The 50 & 200 DMA stand at ₹299.90/₹287.30.

Suraksha Diagnostic Performance

  • Today's Low
  • ₹334
  • Today's High
  • ₹349
  • 52 Week Low
  • ₹224
  • 52 Week High
  • ₹349
  • Open Price₹335
  • Previous Close₹340
  • Volume124,866
  • 50 DMA₹299.90
  • 100 DMA₹288.90
  • 200 DMA₹287.30

Suraksha Diagnostic Chart

Investment Returns

  • Over 1 Month + 34.5%
  • Over 3 Month + 24.48%
  • Over 6 Month + 28.82%
  • Over 1 Year + 10.16%

Smart Investing Starts Here Start SIP with Suraksha Diagnostic for Steady Growth!

Invest Now

Suraksha Diagnostic Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 48.8
  • PEG Ratio
  • 6.5
  • Market Cap Cr
  • 1,748
  • P/B Ratio
  • 6.8
  • Average True Range
  • 13
  • EPS
  • 6.9
  • Dividend Yield
  • 0
  • MACD Signal
  • 16.4
  • RSI
  • 64.76
  • MFI
  • 73.99

Latest Stock News Updates

Suraksha Diagnostic Ltd - 544293 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Please find enclosed the Newspaper Advertisement published on Monday, 31st August, 2026 with respect to the "Notice of 21st Annual General Meeting and e-voting information."

Suraksha Diagnostic Ltd - 544293 - Intimation Under Regulation 30 And 36(1)(B) Of The Securities And Exchange Board Of India (Listing Obligations & Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations)

Please find enclosed the letter sent to those shareholders whose e-mail address are not registered, providing the web link of the Company''s website from where Annual Report for the Financial year 2025-26 can be accessed.

Suraksha Diagnostic Ltd - 544293 - Notice For The 21St Annual General Meeting (AGM) Of The Company

Please find enclosed the Notice of 21st Annual General Meeting of the Company scheduled to be held on 22nd September, 2026

Suraksha Diagnostic Financials

Suraksha Diagnostic Technicals

EMA & SMA

Current Price
₹335.65
-4.45 (-1.31%)
pointer
  • Bearish Moving Average 3
  • Bullish Moving Average 13
  • 20 Day
  • ₹322.50
  • 50 Day
  • ₹299.90
  • 100 Day
  • ₹288.90
  • 200 Day
  • ₹287.30

Resistance and Support

339.42 Pivot Speed
  • R3 360.60
  • R2 354.80
  • R1 345.20
  • S1 329.80
  • S2 324.00
  • S3 314.40

Suraksha Diagnostic Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-08-12 A.G.M.
2026-05-21 Audited Results & Final Dividend
2026-02-05 Quarterly Results
2025-11-10 Quarterly Results
2025-08-08 Quarterly Results
Date Purpose Remarks
2026-09-15 FINAL Rs.0.50 per share(25%)Final Dividend (RD & XD dates revised)
View Suraksha Diagnostic Dividend History Arrow

Suraksha Diagnostic Shareholding Pattern

49.1%
20.05%
14.2%
13.47%
3.17%

About Suraksha Diagnostic

Suraksha Diagnostic is engaged in the business of running diagnostic centres for carrying out various pathological and radiological services. View More
  • NSE Symbol
  • SURAKSHA
  • BSE Symbol
  • 544293
  • Executive Director,Joint Managing Director,Chief Executive Officer
  • Ms. Ritu Mittal
  • ISIN
  • INE877V01027

Similar Stocks to Suraksha Diagnostic

Suraksha Diagnostic FAQs

Suraksha Diagnostic share price is ₹335 As on 10 September, 2026 | 07:44

The Market Cap of Suraksha Diagnostic is ₹1748.1 Cr As on 10 September, 2026 | 07:44

The P/E ratio of Suraksha Diagnostic is 48.8 As on 10 September, 2026 | 07:44

The PB ratio of Suraksha Diagnostic is 6.8 As on 10 September, 2026 | 07:44

The 52 week High & Low of Suraksha Diagnostic is ₹349/₹224.1 respectively As on 10 September, 2026 | 07:44

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23